4 Einträge gefunden

1. HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer

   1. Ghadban, Tarik
   2. Dibbern, Judith L
   3. Reeh, Matthias
   4. Miro, Jameel T
   5. Tsui, Tung Y
   6. Wellner, Ulrich
   7. Izbicki, Jakob R

   2017 - Forschungsinformationssystem des UKE
2. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines

   1. Ghadban, Tarik
   2. Jessen, André
   3. Reeh, Matthias
   4. Dibbern, Judith L
   5. Mahner, Sven
   6. Mueller, Volkmar
   7. Wellner, Ulrich F

   2016 - Forschungsinformationssystem des UKE
3. EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer

   1. Vashist, Yogesh K
   2. Trump, Florian
   3. Gebauer, Florian
   4. Kutup, Asad
   5. Güngör, Cenap
   6. Kalinin, Viacheslav
   7. Muddasar, Rather

   2014 - Forschungsinformationssystem des UKE
4. The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer

   1. Rawnaq, Tamina
   2. Dietrich, Luisa
   3. Wolters-Eisfeld, Gerrit
   4. Uzunoglu, Faik G
   5. Vashist, Yogesh K
   6. Bachmann, Kai
   7. Simon, Ronald

   2014 - Forschungsinformationssystem des UKE